Oliver Gassmann

Oliver Gassmann
University of St.Gallen · Institute of Technology Management

Prof. Dr.

About

624
Publications
217,878
Reads
How we measure 'reads'
A 'read' is counted each time someone views a publication summary (such as the title, abstract, and list of authors), clicks on a figure, or views or downloads the full-text. Learn more
18,454
Citations
Additional affiliations
May 2012 - September 2012
Stanford University
Position
  • Research Associate
July 2007 - December 2007
University of California, Berkeley
Position
  • Research Associate
December 1996 - March 2002
Schindler
Position
  • VP Technology Management

Publications

Publications (624)
Article
Ecosystems are one of the major trends today. They are based on complementarities, which can take the form of supermodularity or uniqueness and appear on both production and consumption side. Different configurations of complementarity lead to different characteristics of ecosystems with different implications. But which configuration of complement...
Chapter
The patent history in the field of biomedical‐related inventions began in 1873 when microbiologist Louis Pasteur received a patent for his improved yeast‐making invention. Since then, research, inventions and patent protection have become heavily developed along with ethical standards and the legal patent system. Here, we demonstrate practical impl...
Article
Open innovation (OI) holds promise to accelerate, diversify, and innovate research and development (R&D) in the pharmaceutical industry. It remains to be assessed in which way and to what extent OI is leveraged in practice by current pharmaceutical R&D organizations. Therefore, here we comprehensively analyzed 21 research-based pharmaceutical compa...
Article
Without fundamental institutional change, such as a change in laws and regulations, many new technologies cannot achieve their full potential. Efforts to induce institutional change in favor of such technologies are, therefore, increasingly critical for innovative firms. To study how German automotive firms induce change that accommodates autonomou...
Article
Ecosystems have become a major trend in research and practice alike. Within an ecosystem, the so-called orchestrator is considered to be one of the most important roles. However, extant research falls short of explaining how and why this orchestrator role and the resulting tasks of orchestration are allocated to specific ecosystem members. Based on...
Chapter
This article documents the rise and fall of Cambridge Analytica, one of the most controversially and frequently discussed companies in the political space. It showcases how the ingredients for its considerable impact both in the 2016 US presidential election and the Brexit referendum came together in the form of technological developments, the soci...
Chapter
This introduction article lays out a path for successful business innovation, based on several successful practices in several industries. In order to successfully build businesses, companies have to understand the game changing trends in the networked economy where ubiquitous connectivity opens up new opportunities but technologies become commodit...
Chapter
This article discusses the opportunities and risks that come along with patents in the new tech business. It takes into account several examples from tech companies that experienced lawsuits and conflicts with competitors over inventions in scheme, code, technology, and shape. With the rise of automated monitoring, communication, and travel, compan...
Article
Delivering transformative therapies to patients while maintaining growth in the pharmaceutical industry requires an efficient use of research and development (R&D) resources and technologies to develop high-impact new molecular entities (NMEs). However, increasing global R&D competition in the pharmaceutical industry, growing impact of generics and...
Article
Scholars have recently argued that startups and incumbents play differential roles in the disruptive transformations of industries toward sustainability and that the transformations are only likely to succeed if both startups and incumbents contribute. To understand their respective contributions and, thus, to understand how industries make the tra...
Article
Comparative analysis of the R&D efficiency of 14 leading pharmaceutical companies for the years 1999–2018 shows that there is a close positive correlation between R&D spending and the two investigated R&D output parameters, approved NMEs and the cumulative impact factor of their publications. In other words, higher R&D investments (input) were asso...
Article
Full-text available
Contrary to existing literature, startups can be successful orchestrators of ecosystems. Based on nine qualitative case studies, this article introduces four archetypes that shed light on how a startup can fulfill the tasks of an orchestrator and overcome challenges. The findings identify dimensions of standardization/customization and sources of v...
Article
Prominent political and societal stakeholders argue that business models (BMs) are pivotal in making a successful transition to a circular economy (CE). However, the existing CE literature has paid little attention to design choices that allow companies to implement circular business models (CBMs) that meet the requirements of their specific situat...
Article
Full-text available
Artificial Intelligence (AI) reshapes companies and how innovation management is organized. Consistent with rapid technological development and the replacement of human organization, AI may indeed compel management to rethink a company's entire innovation process. In response, we review and explore the implications for future innovation management....
Chapter
A challenge for patent management is to identify ideas worth patenting and to evaluate them appropriately. A structured procedure for the evaluation and selection of patents as well as a continuous review of the patent portfolio are indispensable for cost–benefit optimization. Various qualitative and quantitative evaluation methods have been establ...
Chapter
Successful patent management in a company is rooted choosing the right organizational form. Various internal organizational choices, such as establishing a separate patent department, or directly integrating patent activities into the business subunits, must be done according to the objectives of the patent management. Alternatively, it is also pos...
Chapter
Successful patent management differs from industry to industry. This chapter provides examples from the pharmaceutical, chemical, crop-science, life-science, and consumer goods industries, as well as from electrical engineering and telecommunications, automotive and mechanical engineering, nanotechnology, computer science, financial services and fi...
Chapter
This chapter provides more than references. It looks at some of the broader statistical trends, delves into how to read patent documents, their codes, and classifications. It gives some practical tips on how to search patents, also detailing the large legal jurisdictions, such as the European Patent Office and the European Union Intellectual Proper...
Chapter
Successful patent management also differs depending on the technological domain. This chapter looks at technological fields that are on the rise, fields such as biotechnology, nanotechnology, industry 4.0, software, artificial intelligence, and the blockchain. Managing these technologies requires different approaches to patenting and commercializat...
Chapter
The importance of patent commercialization has increased in recent years. The worldwide increase in licensing activities makes this apparent. A distinction must be made between two types of patent commercialization: internal and external. In this chapter, the typical motives and various forms of patent commercialization are explained. This chapter...
Book
How do you develop business in a world certain to be dominated by Internet of Things, Artificial Intelligence, and the Economy of Things? This book brings together leading scholars from academia, established practitioners, and thought-leading consultants who analyse and provide guidance to answer this question. Case studies, checklists, success fac...
Book
Full-text available
This book provides an overview of the common concepts and building blocks of patent management. It addresses executives in the areas of innovation, R & D, patent and intellectual property management as well as academics and students. The authors give valuable information on the characteristics of patent and intellectual property management, based o...
Chapter
Innovation represents both value through creative effort and is a source of competitive advantage, and as such, has always been susceptible to the dangers of imitation. Only effective innovation protection can ensure sustainable business success, but the protection of innovation using intellectual property rights can help capture value. This assert...
Chapter
A successful patent strategy fits with the corporate strategy. How the company positions itself in terms of products, services, markets, and technologies should also be reflected in the patent strategy. This chapter examines various forms of patent strategies: preventative, defensive, offensive. It discusses both offensive and defensive patenting a...
Article
Full-text available
Ecosystems are formed by organisations that jointly create a value proposition that a single firm could not create in isolation. To deliver this value proposition, the partners need a focal firm, the orchestrator, to be align them towards the joint value proposition. Thus, how orchestrators design the alignment structure of an ecosystem is at the v...
Article
We investigated the state of artificial intelligence (AI) in pharmaceutical research and development (R&D) and outline here a risk and reward perspective regarding digital R&D. Given the novelty of the research area, a combined qualitative and quantitative research method was chosen, including the analysis of annual company reports, investor relati...
Article
Today, virtualizing pharma R&D is increasingly related with data analytics and artificial intelligence (AI), technologies that have been developed by software companies outside the healthcare sector. The process of virtualizing pharma R&D is closely related to the technological advancements that result in the generation of large data sets ranging f...
Article
Immer mehr Unternehmen sind Teil einer jungen, digital geprägten Firmengeneration. Angespornt von den Vorbildern im Silicon Valley revolutionieren sie mit innovativen Technologien und ausgefeilten Geschäftsmodellen gesamte Industrien. Während Google und Co. bereits zu den etablierten Konzernen zählen, arbeiten sich Start-ups wie der Lieferservice D...
Article
Full-text available
Business model innovation is a process that allows firms to build and maintain competitive advantages. However, it imposes major challenges to managers who rely on incomplete cognitive representations while attempting to understand the environmental dynamics that determine a business model’s prospective performance. System Dynamics is a computation...
Article
Recent research suggests that effectuation principles such as flexibility, precommitments, and affordable loss may differ substantially from one another. Responding to the call to clarify the effectuation concept, our study introduces the distinction between promotion‐ and prevention‐focused effectuation principles. It argues that promotion‐focused...
Chapter
Wertschöpfungsketten werden zunehmend realtime über mehrere Stufen vernetzt. Produkte selbst beginnen intelligenter und vernetzter zu werden. Die Digitalisierung ermöglicht neue Geschäftsmodelle und erlaubt es informationsbasierten Wettbewerbern, in fremde Branchen vorzudringen. In B2B-Industrien wird im Rahmen von ‚Industrie 4.0‘ die nächste indus...
Chapter
The formerly fully integrated pharma value chain is disaggregating given the emergence of highly capable and specialized research and clinical development service providers. The options range from outsourcing, out-licensing, and in-licensing, strategic partnerships and co-development. These concepts are discussed in detail and illustrated with case...
Chapter
More than in most other industries, the success of pharma R&D hinges on efficient and intelligent pipeline management. All activities and tasks in the research and development phases are highly regulated and defined with precision—a prime example of a stage-gate process. Given the long duration of the development of a new drug, and the increasing R...
Chapter
This final chapter summarizes the key conclusions from the book, identifies key trends and suggests future directions in leading pharmaceutical innovation on three levels: (1) Increasing R&D efficiency and effectiveness; (2) redefining and rethinking the business model, and (3) leading people for innovation and change. Each of these levels is discu...
Chapter
Pharma innovation is becoming increasingly global, partly due to the lure of serving new markets, partly because of the need to access early new technology and talent wherever it emerges. Apart from the established centers of innovation in the United States, Europe and Japan, India, China and Singapore are rising attractors for global life science...
Chapter
The traditional model of innovation in the pharmaceutical industry is being challenged by an explosion of costs for R&D, a strengthened voice of the customer and regulatory bodies in the development of new medicines, and the vanishing of easy targets. An overview is given of established and emerging pharma companies, the cost structures for pharma...
Chapter
Already a high-tech industry by virtue of its science underpinnings, pharma innovation is undergoing a major shift in the wake of the adoption of several new discovery and development technologies. The rise of the biotech industry is the most obvious one, but new approaches in target discovery, high-throughput screening, combinatorial chemistry, hi...
Chapter
Although the pharma industry is primarily based on a science-driven paradigm, the industry itself is highly complex with multiple stakeholders and actors. We employ Porter’s Five-Forces industry analysis to examine the power of suppliers and buyers, potential competitors, the threat of substitute products, and rivalry among established companies. R...
Book
This book investigates and highlights the most critical challenges the pharmaceutical industry faces in an increasingly competitive environment of inflationary R&D investments and tightening cost control pressures. The authors present three sources of pharmaceutical innovation: new management methods in the drug development pipeline; new technologi...
Chapter
Der Artikel definiert Entrepreneurial Innovation und zeigt Wege auf, um Innovation und Neuerungen unternehmerisch voranzutreiben. Dabei werden die zentralen Gestaltungsansätze von Entrepreneurial Innovation erläutert und in strukturelle Ausprägungen und Verhaltensausprägungen unterschieden. Die Relevanz dieser Gestaltungsansätze wird anhand zahlrei...
Book
This book investigates and highlights the most critical challenges the pharmaceutical industry faces in an increasingly competitive environment of inflationary R&D investments and tightening cost control pressures. The authors present three sources of pharmaceutical innovation: new management methods in the drug development pipeline; new technologi...
Chapter
Patent aggregating companies are institutions that aggregate patents for different purposes. From a managerial perspective as well as a theoretical perspective, it is interesting to understand what value such novel business models provide to inventing companies. In this paper we focus on the question how patent holders can use patent aggregating co...
Article
Erfolgreiches Patentmanagement unterscheidet sich von Branche zu Branche. In diesem Kapitel werden mit Beispielen aus den Branchen Pharma & Chemie, Biotechnologie, Konsumgüterindustrie, Elektrotechnik & Telekommunikation, Automobil- & Maschinenbau, Nanotechnologie, Software, Finanzdienstleistungen sowie Transport & Logistik die branchenspezifischen...
Article
This paper looks into how new ventures organize their business models in order to meet their available resources. It employs the business model as the unit of analysis to investigate the role and nature of business model adaptation as a coping mechanism with resource constraints. By drawing on a case study with two ventures starting with different...
Chapter
Ausgehend von der aktuellen Entwicklung geben ausgewiesene Experten einen Querschnitt und Überblick über Industrie 4.0 sowie seine derzeit gelebte Praxis auf einer internationalisierten Ebene. Dazu wird in einem ersten Teil der Beitrag von Innovationsmanagement zur Entwicklung von Industrie 4.0 angegeben, der von den grundlegenden Techniken über e...
Article
This study investigates business models for frugal innovation (i.e. a specific form of resource-constrained innovation) in the medical device and laboratory equipment industry in the context of emerging markets. Based on original data from five case studies, we investigate how firms can set up value creation and value capturing mechanisms to reach...
Research
Full-text available
Frugal innovation, when focused consistently on customers in emerging markets, can open up completely new markets for companies
Research
Full-text available
Konsequent auf die Kunden in Schwellenländern ausgerichtet, kann Frugal Innovation Unternehmen völlig neue Märkte erschließen
Article
Purpose In the intellectual property (IP) and management literature, the question of how external patent attorneys impact patent filings has been understudied. The purpose of this paper is to advance this area of research by examining how the use of external patent attorneys influences the patent filing strategies of firms and what impact firms’ le...